BioCentury
ARTICLE | Clinical News

Inhale reports Phase II inhaleable insulin data

June 14, 2000 7:00 AM UTC

INHL and partners Pfizer (PFE) and Aventis Pharma (AVE; NM:AVE; DAX:AVE) said data from 83 patients in its Phase II extension study of inhaleable insulin showed stable long term blood glucose levels f...